Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study

Autor: Bijal D. Shah, Armin Ghobadi, Olalekan O. Oluwole, Aaron C. Logan, Nicolas Boissel, Ryan D. Cassaday, Thibaut Leguay, Michael R. Bishop, Max S. Topp, Dimitrios Tzachanis, Kristen M. O’Dwyer, Martha L. Arellano, Yi Lin, Maria R. Baer, Gary J. Schiller, Jae H. Park, Marion Subklewe, Mehrdad Abedi, Monique C. Minnema, William G. Wierda, Daniel J. DeAngelo, Patrick Stiff, Deepa Jeyakumar, Jinghui Dong, Sabina Adhikary, Lang Zhou, Petra C. Schuberth, Imi Faghmous, Behzad Kharabi Masouleh, Roch Houot

Publikováno v: Journal of hematology & oncology, vol 15, iss 1
Journal of Hematology and Oncology
Journal of Hematology and Oncology, 2022, 15 (1), pp.170. ⟨10.1186/s13045-022-01379-0⟩

Background Brexucabtagene autoleucel (KTE-X19) is an autologous anti-CD19 CAR T-cell therapy approved in the USA to treat adult patients with relapsed or refractory B-precursor acute lymphoblastic leukemia (R/R B-ALL) based on ZUMA-3 study results. W

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5e535f707491b52d5e9e38e372d3320
https://pubmed.ncbi.nlm.nih.gov/36494725

Integration of genomic sequencing into the response to the Ebola virus outbreak in Nord Kivu, Democratic Republic of the Congo

Autor: Francois Edidi-Atani, Moussa Moïse Diagne, Meris Matondo-Kuamfumu, Junior Bulabula, Kristian G. Andersen, Bibiche Nsunda, Eric Delaporte, Bailey White, Amadou A. Sall, Trevor Bedford, Matthias Pauthner, Martine Peeters, Nella Bisento, Jean Jacques Muyembe Tamfum, Marceline Akonga, James Hadfield, Daniel Mukadi, Michael R. Wiley, Gustavo Palacios, Fabrice Mambu-Mbika, Amuri Aziza, Nicholas Di Paola, Steve Ahuka-Mundeke, Eddy Kinganda-Lusamaki, Catherine Pratt, Ousmane Faye, Martin Faye, Allison Black, Placide Mbala-Kingebeni

Publikováno v: Nat Med
Nature Medicine
Nature Medicine, 2021, 27 (4), pp.710-716. ⟨10.1038/s41591-021-01302-z⟩

On 1 August 2018, the Democratic Republic of the Congo (DRC) declared its tenth Ebola virus disease (EVD) outbreak. To aid the epidemiologic response, the Institut National de Recherche Biomedicale (INRB) implemented an end-to-end genomic surveillanc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::227ccff0ce444d0fb27dd297b6dc0920
https://doi.org/10.1038/s41591-021-01302-z

COVID19 and acute lymphoblastic leukemias of children and adolescents: updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE)

Autor: Jérémie Rouger-Gaudichon, Yves Bertrand, Nicolas Boissel, Benoit Brethon, Stéphane Ducassou, Virginie Gandemer, Carine Halfon-Domenech, Thierry Leblanc, Guy Leverger, Gérard Michel, Arnaud Petit, Anne-France Ray-Lunven, Pierre-Simon Rohrlich, Pascale Schneider, Nicolas Sirvent, Marion Strullu, André Baruchel

Publikováno v: Bulletin du Cancer
Bulletin du Cancer, 2021, 108 (5), pp.490-500. ⟨10.1016/j.bulcan.2021.02.004⟩

Depuis l’émergence de l’infection à SARS-CoV-2, de très nombreuses recommandations ont été émises. Cependant la nature de la maladie et la spécificité du traitement des leucémies aiguës lymphoblastiques de l’enfant et de l’adolescen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27e77e99033d737d9e0374c1e4947a23
http://europepmc.org/articles/PMC7951944

Urinary tract infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society

Autor: C. Donzé, C. Papeix, C. Lebrun-Frenay, C. Lebrun-Frénay, N. Collongues, M. de Seze, A. Dinh, A. Even, C. Scheiber-Nogueira, C. Bensa, B. Bourre, C. Carra-Dallière, J. Ciron, M. Cohen, A.M. Guennoc, C. Louapre, F. Lebreton, L. Michel, E. Maillart, B. Audoin, X. Ayrignac, P. Bernady, B. Brochet, P. Clavelou, R. Colamarino, A. Declemy, J. de Seze, N. Derache, J.-M. Faucheux, O. Heinzlef, P. Labauge, D. Laplaud, E. Lepage, E. Leray, L. Magy, G. Mathey, C. Mekies, V. Mondain, E. Planque, J. Pelletier, S. Pittion, B. Stankhof, P. Tournaire, E. Thouvenot, S. Vukusic, S. Wiertlevski, H. Zephir, H. Alchaar, G. Androdias, M. Benazet, D. Bensmail, D. Biotti, A. Blanchard-Dauphin, M. Bonnan, C. Boutière, P. Branger, S. Bresch, J.-P. Bru, J.-P. Camdessanché, E. Castel Canal, M. Coustans, O. Casez, B. Castan, A. Creange, E. Creisson, T. De Broucker, R. Depaz, X. Douay, C. Dulau, F. Durand-Dubief, O. Fagniez, M. Faucher, A. Floch, M. Fournier, A. Fromont, P. Gallien, X. Gamé, D. Gault, A. Gayou, M. Giroux, O. Gout, J. Grimaud, P. Hautecoeur, A. Kerbrat, L. Kremer, A. Kwiatkowski, C. Labeyrie, S. Lachaud, C. Lanctin-Garcia, L. Lanotte, E. Manchon, A. Maurousset, A.-M. Milor, X. Moisset, A. Mont-Cuquet, T. Moreau, J.-C. Ouallet, I. Patry, D. Peaureaux, M.-C. Pouget, V. Pourcher Martinez, C. Radot, A. Ruet, C. Saint-Val, A. Salmon, F. Taithe, P. Tatevin, M. Vaillant, J.-P. Stahl, F. Vuoto, C. Zaenker

Publikováno v: Revue Neurologique
Revue Neurologique, 2020, 176 (10), pp.804-822. ⟨10.1016/j.neurol.2020.02.011⟩
Revue Neurologique, Elsevier Masson, 2020, 176 (10), pp.804-822. ⟨10.1016/j.neurol.2020.02.011⟩

Objectives Establish recommendations for the management of UTIs in MS patients. Background Urinary tract infections (UTIs) are common during multiple sclerosis (MS) and are one of the most common comorbidities potentially responsible for deaths from

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a5dfd3e0390728753246cc4048803eb
https://hal.umontpellier.fr/hal-03339824

High-intensity lipid-lowering regimens in patients with stable coronary artery disease: the intriguing question of all-cause mortality

Autor: Nicolas Danchin, Tabassome Simon

Publikováno v: European Heart Journal-Cardiovascular Pharmacotherapy
European Heart Journal-Cardiovascular Pharmacotherapy, Oxford Academy, 2020, 6 (5), pp.328-330. ⟨10.1093/ehjcvp/pvz049⟩
European Heart Journal-Cardiovascular Pharmacotherapy, Oxford Academy, 2020, 6 (4), pp.328-330. ⟨10.1093/ehjcvp/pvz049⟩
European Heart Journal — Cardiovascular Pharmacotherapy

International audience; Full secondary prevention medication regimen is often under-prescribed after acute myocardial infarction.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e4d70c11d85bdc0174d28780b7298a8
https://hal.archives-ouvertes.fr/hal-03028540